Advertisement

Topics

Ocular Surface Center, P.A. Company Profile

09:27 EST 15th December 2018 | BioPortfolio

Ocular Surface Foundation (OSF) is a non-profit public medical research foundation (501c3) established in 1999, and carries s single mission of promoting the spread of the knowledge and skills that are important for treating ocular surface diseases. Under the leadership of the President, Billy K. Yeh, M.D., Ph.D., OSF supports research and educational programs that may create a differentiable value in treating these diseases. OSF believes that one way of accomplishing this mission is to promote the education and training of young ophthalmologists that will be specialized in the diagnosis and treatment of these diseases. OSF also believes that one important way of gaining such new knowledge and skills is through effective research and educational programs

Location

7000 SW 97th Ave,Suite 213
Miami
Florida
33173
United States of America

Contact

Phone: (305) 274-1299
Fax: (305) 274-1297
Email: stseng@ocularsurface.com


News Articles [943 Associated News Articles listed on BioPortfolio]

Comment on: Proposal for a new classification for ocular surface squamous neoplasia

Response to ‘Comment on: Proposal for a new classification for ocular surface squamous neoplasia’

FDA Approves Treatment for Ocular Pain Following Surgery

NewsDextenza has the potential to replace a complex eye drop regimen that under the current standard of care requires up to 70 topical ocular steroid drops.

Don't Overlook Ocular Surface Disease Before Cataract Surgery

Dr Sumit (Sam) Garg on the risks of failing to preoperatively diagnose this highly prevalent condition. Medscape Ophthalmology

Ocular Therapeutix files third NDA for ocular pain drug

A new drug application was filed for the third time by Ocular Therapeutix for Dextenza, or dexamethasone insert, 0.4 mg to tr -More- 

Ocular Therapeutix resubmits NDA for DEXTENZA

Ocular Therapeutix™, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announced th...

Grossnickle Eye Center Welcomes Austin Lifferth, OD

Austin Lifferth, OD, joins Grossnickle Eye Center to serve patients in Warsaw, Mishawaka, and Plymouth. SOUTH BEND, Ind. (PRWEB) August 02, 2018 In August, Grossnickle Eye Center welcomes Austin Liff...

Are These Ocular Symptoms Common or Concerning?

Can you correctly categorize these five common ocular symptoms and determine which might potentially indicate a worrisome pathology? Medscape Ophthalmology

Drugs and Medications [401 Associated Drugs and Medications listed on BioPortfolio]

Puralube [Fera Pharmaceuticals]

Drug Facts

Sterilube ointment [Fera Pharmaceuticals]

DRUG FACTS

Akten [Akorn, Inc.]

These highlights do not include all the information needed to use AKTEN safely and effectively. See full prescribing information for AKTEN. AKTEN (lidocaine hydrochloride) gel for ophthalmic use Initi...

Bacitracin [Rebel Distributors Corp]

BACITRACIN OPHTHALMICOINTMENT USPSTERILE

Bacitracin ophthalmic ointment usp sterile [E. FOUGERA and CO.]

BACITRACIN OPHTHALMIC OINTMENT USP STERILE

PubMed Articles [2570 Associated PubMed Articles listed on BioPortfolio]

Corneal fluorescein staining and ocular symptoms but not Schirmer test are useful as indicators of response to treatment in chronic ocular GVHD.

To evaluate long-term ocular surface clinical signs and symptoms response to therapy in patients with chronic ocular GVHD.

A Review of the Cytokine IL-17 in Ocular Surface and Corneal Disease.

To investigate the role of interleukin-17 in ocular surface and corneal disease. Ocular surface and corneal disease is a leading cause of blindness and is an ongoing challenge for the public health se...

Altered expression level of inflammation-related genes and long-term changes in ocular surface after trabeculectomy, a prospective cohort study.

We aim to evaluate changes in the ocular surface in a cohort of post-trabeculectomy patients and whether these were associated with conjunctival inflammatory gene expression.

Visions of Eye Commensals: The Known and the Unknown About How the Microbiome Affects Eye Disease.

Until recently, the ocular surface is thought by many to be sterile and devoid of living microbes. It is now becoming clear that this may not be the case. Recent and sophisticated PCR analyses have sh...

Ethnic differences between the Asian and Caucasian ocular surface: A co-located adult migrant population cohort study.

To investigate the ethnic differences in tear film quality, ocular surface parameters, and dry eye symptomology between co-located Asian and Caucasian populations.

Clinical Trials [3459 Associated Clinical Trials listed on BioPortfolio]

Surveillance of Ocular Surface Flora (SURFACE)

Topical fluoroquinolones (FQs) have achieved widespread use in ophthalmology for both the treatment and prophylaxis of ocular infections. The present study is set to determine the bacteri...

Ocular Micro-vascular Research Base on Functional Slip Lamp Biomicroscopy

Dry eye disease (DED), as one of the most common ocular surface diseases that affecting visual acuity, is highly associated with ocular surface inflammation. Until now, there is no accurat...

Outcome of Punctal Plugs on Ocular Surface Disease

Ocular surface disease is a common adverse effect of systemic isotretinoin therapy. The investigators consider that punctal plugs is simple procedure with good patient compliance for trea...

Influencing Factors on Dry Eye Syndrome and Ocular Surface Disease

Dry eye syndrome and ocular surface disease are very important ophthalmologic diseases. It is known that various inducers are involved. However, it is still necessary to study how influenc...

Comparison of Ocular Surface Features in Patients With Diabetes and Dry Eye Syndrome

The study aims to compare the differences of ocular surface features in controls and patients with diabetes and dry eye syndrome, to thoroughly evaluate the ocular surface health of diabet...

Companies [1650 Associated Companies listed on BioPortfolio]

Ocular Surface Center, P.A.

Ocular Surface Foundation (OSF) is a non-profit public medical research foundation (501c3) established in 1999, and carries s single mission of promoting the spread of the knowledge and skills that ar...

Ocular Therapeutix, Inc. 

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of t...

Ora, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye using its p...

Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. is a privately held company based in Bedford, MA, focused on the development and commercialization of ophthalmic therapeutic products using its proprietar...

Biohedron.Inc.

Visualizing Protein Complexes• A Pair of Polyhedra• Surface Buried in an Interface• Computing a Surface Between Two Densities• Polyhedra Evaluated at an Interfacial Surface• Densities Evalua...

More Information about "Ocular Surface Center, P.A." on BioPortfolio

We have published hundreds of Ocular Surface Center, P.A. news stories on BioPortfolio along with dozens of Ocular Surface Center, P.A. Clinical Trials and PubMed Articles about Ocular Surface Center, P.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ocular Surface Center, P.A. Companies in our database. You can also find out about relevant Ocular Surface Center, P.A. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record